9 results on '"Chiara Niespolo"'
Search Results
2. Tribbles-1 Expression and Its Function to Control Inflammatory Cytokines, Including Interleukin-8 Levels are Regulated by miRNAs in Macrophages and Prostate Cancer Cells
- Author
-
Chiara Niespolo, Jessica M. Johnston, Sumeet R. Deshmukh, Swapna Satam, Ziyanda Shologu, Oscar Villacanas, Ian M. Sudbery, Heather L. Wilson, and Endre Kiss-Toth
- Subjects
miRNA ,Tribbles ,macrophages ,prostate cancer ,inflammation ,Immunologic diseases. Allergy ,RC581-607 - Abstract
The pseudokinase TRIB1 controls cell function in a range of contexts, by regulating MAP kinase activation and mediating protein degradation via the COP1 ubiquitin ligase. TRIB1 regulates polarization of macrophages and dysregulated Trib1 expression in murine models has been shown to alter atherosclerosis burden and adipose homeostasis. Recently, TRIB1 has also been implicated in the pathogenesis of prostate cancer, where it is often overexpressed, even in the absence of genetic amplification. Well described TRIB1 effectors include MAP kinases and C/EBP transcription factors, both in immune cells and in carcinogenesis. However, the mechanisms that regulate TRIB1 itself remain elusive. Here, we show that the long and conserved 3’untranslated region (3’UTR) of TRIB1 is targeted by miRNAs in macrophage and prostate cancer models. By using a systematic in silico analysis, we identified multiple “high confidence” miRNAs potentially binding to the 3’UTR of TRIB1 and report that miR-101-3p and miR-132-3p are direct regulators of TRIB1 expression and function. Binding of miR-101-3p and miR-132-3p to the 3’UTR of TRIB1 mRNA leads to an increased transcription and secretion of interleukin-8. Our data demonstrate that modulation of TRIB1 by miRNAs alters the inflammatory profile of both human macrophages and prostate cancer cells.
- Published
- 2020
- Full Text
- View/download PDF
3. Tribbles-1 Expression and Its Function to Control Inflammatory Cytokines, Including Interleukin-8 Levels are Regulated by miRNAs in Macrophages and Prostate Cancer Cells
- Author
-
Swapna Satam, Sumeet Deshmukh, Ian Sudbery, Oscar Villacanas, Endre Kiss-Toth, Chiara Niespolo, Ziyanda Shologu, Jessica Johnston, and Heather L. Wilson
- Subjects
0301 basic medicine ,Male ,lcsh:Immunologic diseases. Allergy ,Immunology ,Inflammation ,Mice, Transgenic ,Protein degradation ,Protein Serine-Threonine Kinases ,medicine.disease_cause ,Proinflammatory cytokine ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Cell Line, Tumor ,microRNA ,medicine ,Immunology and Allergy ,Animals ,Humans ,Interleukin 8 ,RNA, Messenger ,Transcription factor ,3' Untranslated Regions ,Original Research ,miRNA ,Binding Sites ,Tribbles ,Macrophages ,Mirna ,Prostate Cancer ,biology ,Interleukin-8 ,Intracellular Signaling Peptides and Proteins ,Prostatic Neoplasms ,prostate cancer ,3. Good health ,Ubiquitin ligase ,Cell biology ,macrophages ,MicroRNAs ,030104 developmental biology ,Phenotype ,Gene Expression Regulation ,inflammation ,030220 oncology & carcinogenesis ,biology.protein ,Cytokines ,medicine.symptom ,Carcinogenesis ,lcsh:RC581-607 - Abstract
The pseudokinase TRIB1 controls cell function in a range of contexts, by regulating MAP kinase activation and mediating protein degradation via the COP1 ubiquitin ligase. TRIB1 regulates polarization of macrophages and dysregulated Trib1 expression in murine models has been shown to alter atherosclerosis burden and adipose homeostasis. Recently, TRIB1 has also been implicated in the pathogenesis of prostate cancer, where it is often overexpressed, even in the absence of genetic amplification. Well described TRIB1 effectors include MAP kinases and C/EBP transcription factors, both in immune cells and in carcinogenesis. However, the mechanisms that regulate TRIB1 itself remain elusive. Here, we show that the long and conserved 3’untranslated region (3’UTR) of TRIB1 is targeted by miRNAs in macrophage and prostate cancer models. By using a systematic in silico analysis, we identified multiple “high confidence” miRNAs potentially binding to the 3’UTR of TRIB1 and report that miR-101-3p and miR-132-3p are direct regulators of TRIB1 expression and function. Binding of miR-101-3p and miR-132-3p to the 3’UTR of TRIB1 mRNA leads to an increased transcription and secretion of interleukin-8. Our data demonstrate that modulation of TRIB1 by miRNAs alters the inflammatory profile of both human macrophages and prostate cancer cells.
- Published
- 2020
4. Genomic and Functional Regulation of TRIB1 Contributes to Prostate Cancer Pathogenesis
- Author
-
Amaia Zabala-Letona, Laura Camacho, Maider Bizkarguenaga, Endre Kiss-Toth, Arkaitz Carracedo, Ianire Astobiza, Isabel Mendizabal, Parastoo Shahrouzi, Ruben Caloto, Chiara Niespolo, Guillermo Velasco, Alice Macchia, Edurne Berra, Ana R. Cortazar, Juana M. Flores, Xosé R. Bustelo, Leire Arreal, María L. Martínez-Chantar, Verónica Torrano, Amaia Ercilla, European Commission, Fundación Vasca de Innovación e Investigación Sanitarias, Asociación Española Contra el Cáncer, Ministerio de Ciencia, Innovación y Universidades (España), Agencia Estatal de Investigación (España), Ministerio de Economía y Competitividad (España), Eusko Jaurlaritza, Fundación BBVA, Fundación 'la Caixa', European Research Council, Instituto de Salud Carlos III, and Centro de Investigación Biomédica en Red Cáncer (España)
- Subjects
0301 basic medicine ,Cancer Research ,Disease ,Biology ,Mouse models ,lcsh:RC254-282 ,Article ,Oncología ,Pathogenesis ,03 medical and health sciences ,Prostate cancer ,0302 clinical medicine ,Transcription (biology) ,medicine ,mouse models ,Transcription factor ,Gene ,cMYC ,Oncogene ,TRIB1 ,Amplicon ,medicine.disease ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,prostate cancer ,Genética ,3. Good health ,030104 developmental biology ,Oncology ,030220 oncology & carcinogenesis ,Cancer research - Abstract
© 2020 by the authors., Prostate cancer is the most frequent malignancy in European men and the second worldwide. One of the major oncogenic events in this disease includes amplification of the transcription factor cMYC. Amplification of this oncogene in chromosome 8q24 occurs concomitantly with the copy number increase in a subset of neighboring genes and regulatory elements, but their contribution to disease pathogenesis is poorly understood. Here we show that TRIB1 is among the most robustly upregulated coding genes within the 8q24 amplicon in prostate cancer. Moreover, we demonstrate that TRIB1 amplification and overexpression are frequent in this tumor type. Importantly, we find that, parallel to its amplification, TRIB1 transcription is controlled by cMYC. Mouse modeling and functional analysis revealed that aberrant TRIB1 expression is causal to prostate cancer pathogenesis. In sum, we provide unprecedented evidence for the regulation and function of TRIB1 in prostate cancer., We are grateful to the Carracedo lab for valuable input, to Ana M. Aransay and F. Elortza for technical advice. P.S. was funded by the European Training Networks Project (H2020-MSCA-ITN-308 2016 721532). V.T. is funded by Fundación Vasca de Innovación e Investigación Sanitarias, BIOEF (BIO15/CA/052), the AECC J.P. Bizkaia, the Basque Department of Health (2016111109) and the MICINN RTI2018-097267-B-I00. A. Macchia was funded by a FPI predoctoral fellowship from MICINN (PRE2018-083607). EB is funded by the MICINN (BFU2016-76872-R (FEDER/EU), PID2019-108112RB-I00, Severo Ochoa Excellence Accreditation SEV-2016-0644 and Excellence Networks SAF2017-90794-REDT). The work of A. Carracedo is supported by the Basque Department of Industry, Tourism and Trade (Elkartek), the department of education (IKERTALDE IT1106-16) and health (RIS3), the BBVA foundation and the MICINN (SAF2016-79381-R (FEDER/EU; PID2019-108787RB-I00) Severo Ochoa Excellence Accreditation SEV-2016-0644 and Excellence Networks SAF2016-81975-REDT and RED2018-102769-T), European Training Networks Project (H2020-MSCA-ITN-308 2016 721532), the AECC (IDEAS175CARR, GCTRA18006CARR), La Caixa Foundation (ID 100010434), under the agreement LCF/PR/HR17/ and the European Research Council (Starting Grant 336343, Consolidator Grant 819242). CIBERONC was co-funded with FEDER funds and funded by ISCIII.
- Published
- 2020
5. Neutrophil microvesicles drive atherosclerosis by delivering miR-155 to atheroprone endothelium
- Author
-
Victoria Ridger, Chiara Recarti, Marwa Mahmoud, Andreas Schober, Amanda Burnett, Merete Long, Ingrid Gomez, Ben Ward, Jessica Johnston, Marc A. M. J. van Zandvoort, Sheila E. Francis, Siôn A Parry, Paul G. Hellewell, Endre Kiss-Toth, Mark P. Ariaans, Celine Souilhol, Le Anh Luong, Rohit Bazaz, Laura West, Rachel M Woods, Birke J. Benedikter, Chiara Niespolo, Paul C. Evans, Carl J. Hulston, Med Microbiol, Infect Dis & Infect Prev, RS: NUTRIM - R2 - Liver and digestive health, RS: Carim - B06 Imaging, and Moleculaire Celbiologie
- Subjects
0301 basic medicine ,Mice, Knockout, ApoE ,Neutrophils ,General Physics and Astronomy ,030204 cardiovascular system & hematology ,PATHWAY ,Pathogenesis ,Mice ,0302 clinical medicine ,Macrophage ,Platelet ,Lymphocytes ,lcsh:Science ,Multidisciplinary ,Smooth-muscle-cells ,NF-kappa B ,ASSOCIATION ,Plaque, Atherosclerotic ,3. Good health ,FACTOR-KAPPA-B ,medicine.anatomical_structure ,miRNAs ,medicine.symptom ,EXPRESSION ,Adhesion molecule ,Endothelium ,Cell-derived microparticles ,Science ,Activation ,Inflammation ,Diet, High-Fat ,Article ,General Biochemistry, Genetics and Molecular Biology ,miR-155 ,03 medical and health sciences ,microRNA ,medicine ,Animals ,Humans ,business.industry ,Macrophages ,Endothelial Cells ,General Chemistry ,Atherosclerosis ,Microvesicles ,Disease Models, Animal ,MicroRNAs ,030104 developmental biology ,Gene Expression Regulation ,Cancer research ,lcsh:Q ,business - Abstract
Neutrophils are implicated in the pathogenesis of atherosclerosis but are seldom detected in atherosclerotic plaques. We investigated whether neutrophil-derived microvesicles may influence arterial pathophysiology. Here we report that levels of circulating neutrophil microvesicles are enhanced by exposure to a high fat diet, a known risk factor for atherosclerosis. Neutrophil microvesicles accumulate at disease-prone regions of arteries exposed to disturbed flow patterns, and promote vascular inflammation and atherosclerosis in a murine model. Using cultured endothelial cells exposed to disturbed flow, we demonstrate that neutrophil microvesicles promote inflammatory gene expression by delivering miR-155, enhancing NF-κB activation. Similarly, neutrophil microvesicles increase miR-155 and enhance NF-κB at disease-prone sites of disturbed flow in vivo. Enhancement of atherosclerotic plaque formation and increase in macrophage content by neutrophil microvesicles is dependent on miR-155. We conclude that neutrophils contribute to vascular inflammation and atherogenesis through delivery of microvesicles carrying miR-155 to disease-prone regions., The role of neutrophils in the development of atherosclerosis has long been an enigma, with few neutrophils detected within the plaque. Here, the authors show that microvesicles released from neutrophils increase vascular inflammation and enhance atherosclerotic plaque formation through delivery of miR-155.
- Published
- 2020
6. BS25 Investigating the MIR-101-3P/TRIB1 axis in macrophage immunometabolism
- Author
-
Ian Sudbery, Sumeet Deshmukh, Chiara Niespolo, Juan Salamanca Viloria, Oscar Villacanas Perez, Endre Kiss-Toth, and Heather L. Wilson
- Subjects
biology ,business.industry ,Inflammation ,Lipid metabolism ,030204 cardiovascular system & hematology ,Phenotype ,Cell biology ,03 medical and health sciences ,0302 clinical medicine ,ABCA1 ,microRNA ,Gene expression ,medicine ,biology.protein ,Macrophage ,030212 general & internal medicine ,medicine.symptom ,Scavenger receptor ,business - Abstract
Introduction MiR-101-3p has been implicated in the regulation of macrophage cholesterol efflux and pro-inflammatory genes by directly targeting ABCA1 and MKP-1, which are both downregulated in atherosclerosis. By using bioinformatic analysis we identified TRIB1 as a direct target of miR-101. The TRIB1 gene plays major roles in myeloid cells, regulating inflammation and lipid metabolism. Its deficiency is associated with a severe reduction of anti-inflammatory tissue macrophages (M2-like cells) and an increase in plasma triglycerides. Here we aimed to uncover the role of miR-101-3p/TRIB1 interaction and its consequences on human macrophage immunometabolism. Methods MiRanda target prediction algorithm was used to identify macrophage-specific miRNAs targeting TRIB1, along with additional web-based tools. MiR-101-3p was selected based on its conservation among species as well as its high predictive score and free energy. A luciferase reporter assay was used to validate the miR-101-3p/TRIB1 interaction, employing a miR-101 mimic and inhibitor. Gene expression (RT-qPCR) and protein analysis (Western Blot) was carried out in human monocyte-derived macrophages (hMDMs) following transient manipulation of TRIB1 and miR-101 levels. Results miR-101-3p has a functional binding site for the 3’UTR of TRIB1 and when overexpressed in hMDMs is able to reduce TRIB1 expression at both mRNA and protein levels. Over-expression of TRIB1 in hMDMs alters the levels of pro-inflammatory genes and scavenger receptors, inducing an M2-like phenotype. Conversely, overexpression of miR-101 is associated with a pro-inflammatory phenotype (M1-like). Conclusion miR-101-3p offers a potential target to simultaneously enhance the expression of ABCA1, MKP-1 and TRIB1, thus improving macrophage lipid metabolism and opposing inflammation, thereby attenuating atherosclerosis development. Conflict of interest No
- Published
- 2019
7. Post-transcriptional regulation of trib1 by mirnas in primary macrophages
- Author
-
Chiara Niespolo, Juan Salamanca Viloria, Oscar Villacanas Perez, Heather Wilson, and Endre Kiss-Toth
- Published
- 2018
- Full Text
- View/download PDF
8. microRNAs regulating Tribbles-1: potential molecular targets in prostate cancer
- Author
-
S.S Socorro, Z. Shologu, Alessandra Iscaro, S Satam, Heather L. Wilson, Chiara Niespolo, Endre Kiss-Toth, and Munitta Muthana
- Subjects
Prostate cancer ,business.industry ,Urology ,microRNA ,Cancer research ,Molecular targets ,Medicine ,business ,medicine.disease - Published
- 2019
9. P26 MIR-101-3P CONTROLS TRIB1 EXPRESSION IN HUMAN MACROPHAGES: A POTENTIAL TARGET IN ATHEROSCLEROTIC PLAQUES
- Author
-
Endre Kiss-Toth, Heather L. Wilson, Juan Salamanca Viloria, Chiara Niespolo, and Oscar Villacanas Perez
- Subjects
0301 basic medicine ,Physiology ,Chemistry ,Mir 101 3p ,medicine.disease ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Atheroma ,Physiology (medical) ,medicine ,Cancer research ,Cardiology and Cardiovascular Medicine ,030215 immunology - Published
- 2018
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.